Deok-ho Lim of NEL Animal Cardiovascular Center Delivers Keynote Speech at Jiangsu Province Pet Economic Development Conference

HUAIAN, China–(BUSINESS WIRE)–#2ndJiangsuProvincePetEconomicDevelopmentConference–Deok-ho Lim, director at SV Cross-border Group, a company specializing in the international expansion of hospitals and veterinary clinics in Asia, gave a keynote address at the “2nd Jiangsu Province Pet Economic Development Conference,” where he declared, “The era of searching is over, and the era of answering has arrived.” Lim, who is … [Read more…]

Zepp Health Acquires Core Assets of Wild.AI to Expand Support for Female Athletes Across Life Stages

MILPITAS, Calif.–(BUSINESS WIRE)–#DiscoverAmazing–Zepp Health (NYSE: ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women’s wellness platform focused on optimizing female performance through hormone-informed coaching. The acquisition was completed at the end of August and includes Wild.AI’s proprietary technology and select members of … [Read more…]

Octave Bioscience Announces $35M Series C Financing to Accelerate Commercial Momentum

MENLO PARK, Calif.–(BUSINESS WIRE)–Octave Bioscience, Inc., a commercial stage precision care company that is pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, today announces the close of its $35.6 million Series C equity financing and that it has entered into a $15.5 million non-dilutive term loan agreement with Silicon Valley … [Read more…]

The SCIEX BioPhase 8800 System Harnesses New Native Fluorescence Detection for Protein-Based CE Assays

MARLBOROUGH, Mass.–(BUSINESS WIRE)–#NFD–At CE Pharm, SCIEX, a global leader in life science analytical technologies, launches new native fluorescence detection on the BioPhase 8800 system. To ensure drug safety and efficacy, multiple critical quality attributes such as purity, fragmentation, aggregation, and post-translational modifications need to be well-characterized and monitored. Assays like CE-SDS and cIEF offer automated … [Read more…]

New Study From WellSky® Reveals Generational Differences in Healthcare Career Perceptions

In the midst of ongoing workforce shortages, the findings underscore the need—and opportunity—to better engage and retain the next generation of talent OVERLAND PARK, Kan.–(BUSINESS WIRE)–WellSky, a global health and community care technology and services company, today announced results from a national study of the healthcare workforce conducted in partnership with The Center for Generational … [Read more…]

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company’s 2017 Equity Incentive Plan, but … [Read more…]

Boomerang Medical Raises $20 Million Series B to Advance Pivotal Trial of Neuromodulation in Inflammatory Bowel Disease

Trial evaluates neuromodulation’s potential role in ulcerative colitis, the most common form of IBD MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–#clinicalresearch–Boomerang Medical, Inc., a women-led bioelectronic medicine company, today announced a $20 million Series B financing co-led by Arboretum Ventures and Hatteras Venture Partners. Proceeds will advance BOOM-IBD2, the first pivotal trial of implantable neuromodulation in inflammatory bowel … [Read more…]

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline

Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approval Strategic partnership with Biocodex in biotherapeutics development and manufacturing adds significant non-dilutive funding in addition to the Series B financing Investment fuels expansion of proprietary CORAL® platform and pipeline GHENT, Belgium–(BUSINESS WIRE)–#Parkinson—MRM … [Read more…]

Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions

BEIJING–(BUSINESS WIRE)–#AntibodyDrugDiscovery—Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies and Merck, a leading science and technology company, have entered into an evaluation and option agreement to advance the development of antibody-conjugated lipid-based delivery solutions for nucleic acid payloads, … [Read more…]

Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

MARLBOROUGH, Mass.–(BUSINESS WIRE)–$HOLX #holx–Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 23rd Annual Morgan Stanley Global Healthcare Conference in New York at 10:45 a.m. Eastern Time on Tuesday, September 9th. The fireside chat presentation will be webcast live and may be accessed through a link on the investors section of … [Read more…]